Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
Nicholas James ShortWalid MacaronMarina Y KonoplevaFarhad RavandiNitin JainGhayas C IssaTapan Mahendra KadiaKoiji SasakiPartow KebriaeiMusa YlimazPhilip A ThompsonKoichi TakahashiHussein A AbbasWilliam G WierdaRebecca GarrisHagop M KantarjianElias J JabbourPublished in: American journal of hematology (2022)